West Branch Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7
| Closed | -$307 | – | 589 |
|
|
2024
Q3 | $307 | Buy |
+7
| New | +$307 | ﹤0.01% | 439 |
|
|
2023
Q4 | – | Sell |
-1,320
| Closed | -$47.9K | – | 450 |
|
|
2023
Q3 | $47.9K | Hold |
1,320
| – | – | 0.03% | 165 |
|
|
2023
Q2 | $47K | Hold |
1,320
| – | – | 0.02% | 168 |
|
|
2023
Q1 | $47K | Sell |
1,320
-80
| -6% | -$2.85K | 0.03% | 171 |
|
|
2022
Q4 | $49.2K | Hold |
1,400
| – | – | 0.03% | 169 |
|
|
2022
Q3 | $41K | Sell |
1,400
-36
| -3% | -$1.05K | 0.03% | 181 |
|
|
2022
Q2 | $78K | Buy |
1,436
+36
| +3% | +$1.96K | 0.05% | 138 |
|
|
2022
Q1 | $76K | Sell |
1,400
-505
| -27% | -$27.4K | 0.04% | 154 |
|
|
2021
Q4 | $95K | Buy |
1,905
+505
| +36% | +$25.2K | 0.04% | 149 |
|
|
2021
Q3 | $67K | Hold |
1,400
| – | – | 0.03% | 166 |
|
|
2021
Q2 | $70K | Buy |
+1,400
| New | +$70K | 0.03% | 171 |
|